Legal & General Group PLC Praxis Precision Medicines, Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.88 - $36.45 $15,600 - $302,462	-8,298 Reduced 65.15%	4,438 $10,000
Q2 2022 Aug 22, 2022	BUY	$1.75 - $11.34 $8,459 - $54,817	4,834 Added 61.17%	12,736 $31,000
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $65,092 - $111,672	4,950 Added 167.68%	7,902 $147,000
Q2 2021 Aug 12, 2021	BUY	$18.28 - $33.05 $32,940 - $59,556	1,802 Added 156.7%	2,952 $54,000
Q1 2021 May 17, 2021	SELL	$29.34 - $60.2 $1,085 - $2,227	-37 Reduced 3.12%	1,150 $38,000
Q4 2020 Feb 12, 2021	BUY	$27.25 - $55.82 $32,345 - $66,258	1,187 New	1,187 $65,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.